Market cap: $1,990,581,109
Exchange: NAS
Sector: Health Technology
Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. The company was founded in 2015 and is headquartered in Lexington, MA.
Company Name
Keros Therapeutics Inc
Average Volume (10 days)
314,704
Average Volume (30 days)
286,773
Moving Average (50 days)
$63.56
Moving Average (200 days)
$47.41
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
1,990,581,109
Shares Outstanding
36,067,786
52-Week High Split Adjust Only
73
52-Week Low Split Adjust Only
27.02
Employee Count
104
Beta
0.8299
Next Earnings Date
2024-05-02
TTM Dividend Rate Per Share
0
Past 5 days
-0.05%
Past 30 days
-0.16%
Past 3 months
-0.01%
Past 6 months
0.94%
Past year
0.22%
Past 2 years
-0.06%
Past 5 years
1.75%
Max % Change
1.75%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | KROS | n/a | n/a | -20.9 | n/a | n/a |
| Peer Avg | N/A | 3.32 | -1.07 | -1.9 | 3.32 | 4.06 |
| Omeros Corporation | OMER | 13.27 | -4.27 | -7.7 | 13.27 | 16.24 |
| Omega Therapeutics Inc | OMGA | n/a | n/a | n/a | n/a | n/a |